IMCY-0098

N/A

Report date: 2024/11/23 20:00:08
NME

Base Information

Drug NameIMCY-0098
Drug Alias NameIMCY-0098
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImcyse Sa
China Registration ClassN/A

Develop Information

Active CompaniesImcyse Sa
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A